Outcome
    Limited

    Evening Primrose Oil for Hot Flash Reduction

    Evening primrose oil reduced hot flash severity (not frequency) in one notable RCT; overall evidence is weaker than black cohosh.

    Overview

    Evening primrose oil reduced hot flash severity (not frequency) in one notable RCT; overall evidence is weaker than black cohosh.

    Verdict

    Mixed evidence

    How It Works

    Gamma-linolenic acid (GLA) is a precursor to anti-inflammatory prostaglandin E1, theorized to modulate vasomotor tone.

    Dosing & Protocol

    Typical dose

    Recommended dose
    500-1000 mg evening primrose oil twice daily (about 1-2 g/day, 80-160 mg GLA); trials show results close to placebo
    Expected timeframe
    6-12 weeks if any effect appears

    Protocol

    dose
    500-1000 mg twice daily
    form
    Softgel standardised to 8-10% GLA
    steps
    Know the odds before starting: randomised trials of evening primrose oil for hot flashes have mostly found it no better than placebo, with at most small changes in severity rather than frequency,If you trial it, take 500-1000 mg twice daily with food for 8-12 weeks,Track hot flash frequency and severity daily — this symptom has a very large placebo response, so a diary matters,Consider the options with real evidence: hormone therapy where appropriate, and non-hormonal prescription options such as SSRIs/SNRIs, gabapentin or fezolinetant,Stop at 12 weeks if the diary shows no change
    timing
    With meals containing fat
    duration
    8-12 week trial, then stop if unchanged

    Evidence

    What the studies say

    A 6-week RCT showed reduced flash severity versus placebo but no change in frequency; other trials are negative. Reasonable safety profile makes it a low-risk trial option, but expectations should be modest.

    No studies are yet linked to both Evening Primrose Oil and Hot Flash Reduction.

    Safety

    Caveats

    Mixed evidence, mostly negative or placebo-level. May lower the seizure threshold — avoid with epilepsy and with phenothiazines. Antiplatelet activity adds bleeding risk with warfarin, DOACs and antiplatelets; stop 2 weeks before surgery. Avoid in pregnancy. GI upset and headache are common at higher doses.

    Less likely to help if

    Most women in controlled trials; those with severe vasomotor symptoms who need hormone therapy or a non-hormonal prescription.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.